AQR Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $129M | Buy |
257,910
+132,228
| +105% | +$63.5M | 0.05% | 535 |
|
|
2026
Q1 | $61.4M | Sell |
125,682
-19,070
| -13% | -$10.3M | 0.03% | 668 |
|
|
2025
Q4 | $83.9M | Sell |
144,752
-10,856
| -7% | -$6.14M | 0.04% | 528 |
|
|
2025
Q3 | $72.4M | Buy |
155,608
+46,918
| +43% | +$21.8M | 0.05% | 505 |
|
|
2025
Q2 | $44.1M | Sell |
108,690
-100,575
| -48% | -$42.1M | 0.04% | 573 |
|
|
2025
Q1 | $102M | Sell |
209,265
-11,937
| -5% | -$6.47M | 0.11% | 262 |
|
|
2024
Q4 | $115M | Buy |
221,202
+9,797
| +5% | +$5.39M | 0.15% | 180 |
|
|
2024
Q3 | $129M | Buy |
211,405
+113,253
| +115% | +$67M | 0.18% | 137 |
|
|
2024
Q2 | $54.3M | Buy |
98,152
+15,009
| +18% | +$8.6M | 0.08% | 309 |
|
|
2024
Q1 | $48.1M | Sell |
83,143
-25,752
| -24% | -$14.5M | 0.08% | 296 |
|
|
2023
Q4 | $57.8M | Sell |
108,895
-48,844
| -31% | -$23.6M | 0.11% | 236 |
|
|
2023
Q3 | $79.8M | Sell |
157,739
-20,937
| -12% | -$11.2M | 0.16% | 155 |
|
|
2023
Q2 | $92.8M | Sell |
178,676
-47,989
| -21% | -$25.9M | 0.2% | 121 |
|
|
2023
Q1 | $129M | Buy |
226,665
+16,194
| +8% | +$9.13M | 0.28% | 76 |
|
|
2022
Q4 | $116M | Sell |
210,471
-34,081
| -14% | -$18.1M | 0.26% | 77 |
|
|
2022
Q3 | $124M | Sell |
244,552
-31,617
| -11% | -$17.7M | 0.3% | 67 |
|
|
2022
Q2 | $147M | Sell |
276,169
-434,559
| -61% | -$239M | 0.33% | 54 |
|
|
2022
Q1 | $420M | Sell |
710,728
-235,464
| -25% | -$135M | 0.8% | 11 |
|
|
2021
Q4 | $631M | Sell |
946,192
-167,591
| -15% | -$105M | 1.14% | 7 |
|
|
2021
Q3 | $636M | Buy |
1,113,783
+49,310
| +5% | +$27.1M | 1.18% | 7 |
|
|
2021
Q2 | $537M | Sell |
1,064,473
-38,546
| -3% | -$18.2M | 0.93% | 10 |
|
|
2021
Q1 | $502M | Buy |
1,103,019
+302,402
| +38% | +$144M | 0.82% | 16 |
|
|
2020
Q4 | $370M | Buy |
800,617
+125,124
| +19% | +$58.7M | 0.66% | 21 |
|
|
2020
Q3 | $297M | Buy |
675,493
+125,333
| +23% | +$51.8M | 0.5% | 36 |
|
|
2020
Q2 | $194M | Sell |
550,160
-15,058
| -3% | -$5.05M | 0.31% | 71 |
|
|
2020
Q1 | $160M | Sell |
565,218
-675,845
| -54% | -$213M | 0.27% | 93 |
|
|
2019
Q4 | $403M | Sell |
1,241,063
-417,282
| -25% | -$127M | 0.46% | 41 |
|
|
2019
Q3 | $483M | Sell |
1,658,345
-483,126
| -23% | -$138M | 0.57% | 25 |
|
|
2019
Q2 | $622M | Buy |
2,141,471
+598,230
| +39% | +$165M | 0.69% | 17 |
|
|
2019
Q1 | $418M | Sell |
1,543,241
-372,305
| -19% | -$92.7M | 0.44% | 43 |
|
|
2018
Q4 | $429M | Buy |
1,915,546
+416,123
| +28% | +$97.6M | 0.5% | 48 |
|
|
2018
Q3 | $366M | Buy |
1,499,423
+624,602
| +71% | +$144M | 0.35% | 68 |
|
|
2018
Q2 | $181M | Buy |
874,821
+427,284
| +95% | +$90.7M | 0.18% | 137 |
|
|
2018
Q1 | $92.4M | Buy |
447,537
+60,971
| +16% | +$12.8M | 0.1% | 243 |
|
|
2017
Q4 | $73.4M | Buy |
386,566
+180,385
| +87% | +$34.6M | 0.08% | 296 |
|
|
2017
Q3 | $39M | Buy |
206,181
+22,468
| +12% | +$4.07M | 0.05% | 434 |
|
|
2017
Q2 | $32.1M | Buy |
183,713
+16,760
| +10% | +$2.82M | 0.04% | 502 |
|
|
2017
Q1 | $25.6M | Sell |
166,953
-3,440
| -2% | -$526K | 0.03% | 538 |
|
|
2016
Q4 | $24M | Buy |
170,393
+1,368
| +0.8% | +$202K | 0.03% | 555 |
|
|
2016
Q3 | $26.9M | Sell |
169,025
-58,761
| -26% | -$9.05M | 0.04% | 511 |
|
|
2016
Q2 | $33.7M | Buy |
227,786
+52,097
| +30% | +$7.69M | 0.06% | 430 |
|
|
2016
Q1 | $24.9M | Sell |
175,689
-72,607
| -29% | -$9.73M | 0.04% | 485 |
|
|
2015
Q4 | $35.2M | Sell |
248,296
-31,793
| -11% | -$4.24M | 0.06% | 405 |
|
|
2015
Q3 | $34.2M | Buy |
280,089
+58,622
| +26% | +$7.64M | 0.07% | 347 |
|
|
2015
Q2 | $28.7M | Buy |
221,467
+88,374
| +66% | +$11.5M | 0.06% | 376 |
|
|
2015
Q1 | $17.9M | Sell |
133,093
-52,984
| -28% | -$6.83M | 0.04% | 408 |
|
|
2014
Q4 | $23.3M | Buy |
186,077
+16,543
| +10% | +$2.01M | 0.05% | 433 |
|
|
2014
Q3 | $20.6M | Sell |
169,534
-79,940
| -32% | -$9.72M | 0.06% | 391 |
|
|
2014
Q2 | $29.4M | Sell |
249,474
-44,000
| -15% | -$5.18M | 0.08% | 324 |
|
|
2014
Q1 | $35.3M | Buy |
293,474
+54,400
| +23% | +$6.47M | 0.11% | 231 |
|
|
2013
Q4 | $26.6M | Buy |
239,074
+26,037
| +12% | +$2.59M | 0.08% | 306 |
|
|
2013
Q3 | $19.6M | Sell |
213,037
-122,971
| -37% | -$11.1M | 0.07% | 345 |
|
|
2013
Q2 | $28.4M | Buy |
+336,008
| New | +$28M | 0.1% | 254 |
|
Other funds holding TMO
AQR Capital Management's TMO Position: Q2 2026 in Review
AQR Capital Management increased its Thermo Fisher Scientific (TMO) stake by 105% in Q2 2026, buying an estimated $63.5M and bringing the position to 257,910 shares worth $129M. The position accounts for 0.05% of the portfolio, ranked #535.
AQR Capital Management first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $636M in Q3 2021. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- AQR Capital Management held 257,910 shares of Thermo Fisher Scientific worth $129M as of Q2 2026.
- AQR Capital Management bought 132,228 Thermo Fisher Scientific shares in Q2 2026, an estimated $63.5M.
- Thermo Fisher Scientific made up 0.05% of AQR Capital Management's portfolio in Q2 2026, its #535 holding.
- AQR Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- AQR Capital Management's Thermo Fisher Scientific position peaked at $636M in Q3 2021.
- 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.